Masimo (MASI) FCF Margin Growth (3y) (2012 - 2026)
Masimo (MASI) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 1,094.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,094.00 |
| Jan 3, 2026 | 2,235.00 |
| Sep 27, 2025 | 1,317.00 |
| Jun 28, 2025 | 2,041.00 |
| Mar 29, 2025 | 192.00 |
| Dec 28, 2024 | -4,234.00 |
| Mar 30, 2024 | -627.00 |
| Sep 30, 2023 | 359.00 |
| Jul 1, 2023 | -3,290.00 |
| Apr 1, 2023 | -239.00 |
| Dec 31, 2022 | -3,168.00 |
| Oct 1, 2022 | -4,194.00 |
| Jul 2, 2022 | -1,270.00 |
| Apr 2, 2022 | -770.00 |
| Jan 1, 2022 | 2,819.00 |
| Apr 3, 2021 | -1,727.00 |
| Sep 26, 2020 | -1,630.00 |
| Jun 27, 2020 | 4,574.00 |
| Mar 28, 2020 | -285.00 |
| Dec 28, 2019 | -14,914.00 |